skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon



Pharma consulting(ファーマコンサルティング)では、経験豊富なコンサルタントが弊社のデータベース群をフル活用し、かつ、外部の情報ソースも利用してお客様のニーズに合わせた個別の市場調査・分析を行います。


  • 自社パイプラインの確率調整済みNPVはどれくらいか?
  • 市場参入時の競合状況はどうなるか?
  • 競争が激しい分野の情報をタイムリーに追跡&視覚化するためにどうすればよい?
  • 承認を受けるための最良の臨床開発経路はどのようなものか?
  • より高い償還価格を実現するには、どのような治験のエンドポイントが役立つか?
  • ある製品にとって最良の臨床試験実施機関をどのように選ぶべきか?
  • 臨床試験のための被験者募集に関する実現可能性とタイムラインはどの程度か?
  • 開発中製品の上市までの時間、成功確率、商業的価値のバランスをどうとるか?


Pharma consultingご利用のメリットを1分間の動画にまとめました。ぜひご覧下さい。


Pharma consultingのシニアディレクター・Timothy Pangが、Pharma consultingサービスのケーススタディを交えて講演を行いました。
1. Bringing data alive: Consulting Case Studies(2018年2月/東京)
2. New horizons, fresh opportunities: Tech, Big Data, and the next pharma wave(2017年11月/東京)



  • HBW Insight : コンシューマーヘルスケア産業のニュース

    EU Coronavirus Situation 'Evolving Very Rapidly' Says AESGP

    In response to the outbreak of the Covid-19 pandemic in Europe, the region's self-care industry is working hard to keep shelves stocked with crucial OTC medicines and food supplements, according to the AESGP.

    Topic Coronavirus

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Covid-19 Disrupting Supply Chains Short-Term, Could Spark Long-Term Procurement Shifts

    UNPA anticipates supplies of a ‘significant number’ of China-sourced supplement ingredients will be ‘critical’ by late April as Covid-19 disrupts shipments. During a recent webinar, UNPA CEO Loren Israelsen said he expects disruptions to continue until at least mid-year.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Coronavirus Disruption Likely In Supply Chain, Stockpiling Spikes Consumer Health Sales

    Hand sanitizer, vitamin, energy drink, first-aid kis and medical face mask sales soar globally as consumers fearing spread of the coronavirus stockpile food and other essentials, a Nielsen report shows. FDA says outbreak could lead to interruptions in drug and medical device supplies; agency has not addressed consumer health supplies specifically, and industry is increasingly concerned with availability.

    Topic Coronavirus

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Coronavirus Slams US Consumer Health Industry Event Schedules, FDA Meetings, Inspections

    In addition to postponing NDAC meeting on food handler antiseptic drug products, FDA is suspending most inspections of foreign manufacturing facilities through April. Latest consumer health industry conferences cancelled or postponed are Consumer Healthcare Product Association and Informa Markets events.

    Topic Coronavirus

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Supplement Industry Summit Postponed, But Sales Jump As Consumers Respond To Covid-19

    Dietary Supplements Regulatory Summit scheduled for 27 May in Washington is postponed. Even as supplies from China are slowed or interrupted due to Covid-19, though, sales of some consumer health products jump as consumers respond to the public health threat.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Bogus Coronavirus Claims For Silver, Essential Oils, Herbalist's Tea 'Protocol' Plus A Price Discount


    Obviously unsubstantiated claims on how the products either prevent or cure the virus didn’t escape FDA and FTC's attention -- they warned seven firms attempting to capitalize on consumer fears. They warnings are the “first step” and they plan to enforce action against companies that continue to market products with treatment claims.

    Topic Coronavirus

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    No Plans To Remove CBD Products From Shelves, Says UK Food Regulator


    CBD products already on the UK market are safe for now, as the country's Food Standards Agency says it will not take action while it works out how to implement the new European Union novel food regulations. 

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    OTC Drug Oversight By US FDA Split Among Two Divisions In Reorganization


    CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Polish Industry Fighting Against Advertising Tax On Supplements

    Advertising dietary supplements in Poland will incur a new tax under proposals from the country's Ministry of Health. While the government claims the motivation is to promote healthy eating choices, industry says supplements have been unfairly linked to poor dietary choices without evidence.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    OTC Zantac And Private Label Ranitidine Numerous In FDA Recall Updates

    In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in FDA's database updates through 9 January are Amneal Pharmaceuticals, Preferred Pharmaceuticals, which distributed products made by Amneal, and Granules India Ltd.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Bayer Harnessing Skin Microbiome In New Product Development

    Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions. 

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    EU Wellness Market In 2019: The CBD Green Rush

    An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Steripod Bolt-on Deal Extends Perrigo Into Toothbrush And Razor Accessories

    Perrigo's Ranir division purchased the brand, which includes a portfolio of antibacterial toothbrush protectors, children’s products and tongue cleaners, for an undisclosed amount from Bonfit America.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    'Supplement' on CBD Product Label A Bullseye For US Litigants, Says Attorney

    Two CBD marketers warned by FDA in a recent crackdown are targeted in class action complaints alleging they made unsubstantiated health claims and mislabeled ‘illegal drug’ products as supplements. Complaints are a wake-up call to CBD wellness industry to ensure claims are substantiated, as the class action bar is on the prowl following the agency’s 15 warning letter blast in November.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Reckitt Targets UK's Painful 'Tweens' With Double-Strength Nurofen

    Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."



Timothy Pang

Consultant, Senior Director- Pharma consulting


Timothy Pang

Timothy specializes in

  • Business Development & Licensing
  • Commercial Strategy

+24 year(s) experience



電話:+81 (0)3 6273 4260